GLP-1 Receptor Agonists: Ozempic Face and Body Composition
The Ozempic face phenomenon describes facial changes caused by GLP-1 receptor agonists during rapid weight loss. These changes include loss of facial fat and skin elasticity affecting body composition. Understanding this helps clinicians counsel patients…
Ozempic Face: GLP-1 Facial Aging & Body Composition
GLP-1 facial volume loss is a recognized effect of rapid weight loss with medications like Ozempic. This phenomenon causes visible facial aging due to loss of subcutaneous fat. Understanding these changes helps clinicians counsel patients effectively.
GLP-1 Weight Loss: Muscle Loss and Body Composition Effects
Rapid weight loss effects from GLP-1 receptor agonists influence muscle loss and body composition changes. Understanding these effects is vital for clinicians managing obesity treatment. This article reviews the physiological impact of GLP-1 therapies on…